# Taiho Pharmaceutical Co., Ltd. – FDA Inspection, Jan 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/taiho-pharmaceutical-co-ltd/1b51b09e-6eb1-4f0e-af84-0bb95d52e471
Source feed: FDA_Inspections

> FDA inspection 1227779 of Taiho Pharmaceutical Co., Ltd., January 26, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1227779
- Company Name: Taiho Pharmaceutical Co., Ltd.
- Inspection Date: 2024-01-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 930223 - 2015-05-22

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nicholas-l-hunt/2f10c080-c02e-4cc3-a8a0-0675b9c4cc6d)

Company: https://www.keypedia.com/companies/taiho-pharmaceutical-co-ltd/3d8b2ff8-dbec-432b-9a10-fabfee17982f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
